On May 22, JD HEALTH (06618) spent HK$29.4463 million to repurchase 729,300 shares.
JD Health (06618) announced that it will spend 29.4463 million Hong Kong dollars to repurchase 729,300 shares on May 22, 2026.
JD HEALTH (06618) announced that on May 22, 2026, it spent 2944.63 million Hong Kong dollars to repurchase 72.93 million shares.
Related Articles
PINE TECH (01079): Wang Shoulei resigns as Executive Director of the company.
HENLIUS (02696): Suluclizumab injection receives positive review from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
Major shareholder ZHU WEI and his spouse of EverProX Technologies (300548.SZ) plan to reduce their total shareholding by not more than 1.37%.
PINE TECH (01079): Wang Shoulei resigns as Executive Director of the company.
HENLIUS (02696): Suluclizumab injection receives positive review from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
Major shareholder ZHU WEI and his spouse of EverProX Technologies (300548.SZ) plan to reduce their total shareholding by not more than 1.37%.
